Purdue Pharma, makers of the painkiller OxyContin, are going to seek U.S. Food and Drug Administration approval to label it for use by children as young as 6.
Oxycontin earned them $2.8 billion last year but drug companies have a tiny window in which they can make any money so they are always looking for creative ways to extend that. Even a 6-month extension is a billion bucks so Purdue is putting together a pediatric trial which will involve 154 children ages 6 to 16 that would finish in August, 2013.
Obviously for children in pain the ability of doctors to go 'off-label' is a good thing, but this isn't just about the kids. And the data on what an opiod could do to a very young brain basically does not exist.
PAINKILLERS FOR KIDS by Karen Keller, The Daily.com
Know Science And Want To Write?
Apply for a column: writing@science20.com
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
- Epidemiologists Can Link Weedkillers To Your Prostate Cancer Even If You Were Never Exposed
- What Did Biden Know And When Did He Know It About The COVID-19 Origin?
- The Buried Lottery
- The Left Abandoning Their War On Vaccines and Nuclear Energy Will Bring a Golden Age To America
- Organic Food Provides Food Poisoning At Los Angeles 'Best Restaurants' Event
- Twenty Years Blogging
- Progressives Are Outraged That Mexico Sided With Science On GMOs
Interesting insights from outside Science 2.0
Comments